000 01488 a2200373 4500
005 20250515190109.0
264 0 _c20100406
008 201004s 0 0 eng d
022 _a1129-2377
024 7 _a10.1007/s10194-009-0157-8
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTfelt-Hansen, Peer C
245 0 0 _aIs there an inherent limit to the efficacy of calcitonin gene-related peptide receptor antagonists in the acute treatment of migraine? A comment.
_h[electronic resource]
260 _bThe journal of headache and pain
_cDec 2009
300 _a389-91 p.
_bdigital
500 _aPublication Type: Editorial
650 0 4 _aAzepines
_xpharmacology
650 0 4 _aCalcitonin Gene-Related Peptide
_xmetabolism
650 0 4 _aCalcitonin Gene-Related Peptide Receptor Antagonists
650 0 4 _aCerebral Arteries
_xdrug effects
650 0 4 _aClinical Trials as Topic
650 0 4 _aDipeptides
_xpharmacology
650 0 4 _aHumans
650 0 4 _aImidazoles
_xpharmacology
650 0 4 _aMigraine Disorders
_xdrug therapy
650 0 4 _aPiperazines
650 0 4 _aQuinazolines
_xpharmacology
650 0 4 _aReceptors, Calcitonin Gene-Related Peptide
_xmetabolism
650 0 4 _aSerotonin Receptor Agonists
_xpharmacology
650 0 4 _aTreatment Failure
650 0 4 _aTryptamines
_xpharmacology
773 0 _tThe journal of headache and pain
_gvol. 10
_gno. 6
_gp. 389-91
856 4 0 _uhttps://doi.org/10.1007/s10194-009-0157-8
_zAvailable from publisher's website
999 _c19176611
_d19176611